HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Département
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublications en collaboration avec des chercheurs de Icahn School of Medicine at Mount Sinai (17)
2023
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057
-
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
JACC: CardioOncology, Vol. 5, Núm. 6, pp. 715-731
2022
-
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
Life science alliance, Vol. 5, Núm. 4
2021
-
Clinical Validation of a 3-Dimensional Ultrafast Cardiac Magnetic Resonance Protocol Including Single Breath-Hold 3-Dimensional Sequences
JACC: Cardiovascular Imaging, Vol. 14, Núm. 9, pp. 1742-1754
-
Triglycerides and Residual Atherosclerotic Risk
Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041
2020
-
Association Between Left Ventricular Noncompaction and Vigorous Physical Activity
Journal of the American College of Cardiology, Vol. 76, Núm. 15, pp. 1723-1733
-
Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum
American Journal of Human Genetics, Vol. 107, Núm. 3, pp. 499-513
2017
-
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
Heart Rhythm, Vol. 14, Núm. 1, pp. e3-e40
2016
-
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication
Journal of Arrhythmia, Vol. 32, Núm. 4, pp. 247-278
-
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
Europace, Vol. 18, Núm. 10, pp. 1455-1490
-
Impact of the Timing of Metoprolol Administration during STEMI on Infarct Size and Ventricular Function
Journal of the American College of Cardiology, Vol. 67, Núm. 18, pp. 2093-2104
2015
-
Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort the PESA (Progression of Early Subclinical Atherosclerosis) study
Circulation, Vol. 131, Núm. 24, pp. 2104-2113
2014
-
Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)
Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362
-
Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"
Circulation
2013
-
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial
Circulation, Vol. 128, Núm. 14, pp. 1495-1503
-
The progression and early detection of subclinical atherosclerosis (PESA) study: Rationale and design
American Heart Journal, Vol. 166, Núm. 6, pp. 990-998
-
Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial
Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649